As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
Preoperative use of GLP-1 receptor agonists did not increase complications or readmissions following body contouring surgery, suggesting these agents are safe in the perioperative setting.
A retrospective review of patients undergoing elective dental procedures found that dexmedetomidine alone was more often associated with oxygen desaturation, while combining dexmedetomidine with ketamine...
A large prospective study found that specific dietary lignans and whole grain foods are associated with a significantly reduced risk of incident gout, highlighting the potential role of the gut microbiome...
A large cohort study of adolescents found that higher restricted normalized isotropic (RNI) values—an MRI-based marker of brain microstructure—were associated with greater weight gain over 2 years,...
Recent studies show distinct metabolic disruptions in children with multisystem inflammatory syndrome in children, plaque progression in adults post–COVID-19, and surprising pneumococcal risk patterns.
...
A global analysis reveals growing diabetes burden linked to alcohol consumption, with projections pointing to continued increases without targeted intervention. This study was presented at the Endocrine...
A retrospective cohort study highlights the potential of GLP-1 receptor agonists to reduce BMI and support glycemic control in adolescents and young adults with type 1 diabetes and obesity without...
A Norwegian cohort study found that walking more than 100 minutes per day was associated with a 23% reduced risk of chronic low back pain, with volume showing a stronger effect than intensity.
In this expert interview, Tugce Akcan, MD, discusses a novel approach to type 1 diabetes care using OpenAPS and GLP-1 receptor agonists to eliminate the need for prandial insulin boluses and improve patient...
